Antiepileptic Drugs Flashcards

Treatment; Slides 55 onwards (101 cards)

1
Q

Cause fewer cognitive impairments (2)

A

Gabapentin and Lamotrigine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

May cause substantial cognitive impairments esp. when given at high or rapid doses

A

Topiramate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Most widely used AEDs (4)

A

Carbamazepine, Phenobarbital, Phenytoin, Valproic Acid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Superior to valproic acid for efficacy in the treatment of
partial seizures

A

Carbamazepine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Newer generation agents (3)

A

Lamotrigine, Oxcarbazepine, Topiramate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Received FDA approval for use as monotherapy in patients
with partial seizures (3)

A

Lamotrigine, Oxcarbazepine, Topiramate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Lamotrigine, Oxcarbazepine, Topiramate are FDA approved as _____________

A

monotherapy in patients
with partial seizures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

traditional treatment for Tonic-Clonic Seizures

A

Phenytoin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

increasingly used due
to lower incidences of side effects and with equal efficacy compared to phenytoin in treating Tonic-Clonic Seizures (2)

A

Carbamazepine and Valproic acid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Generally considered the drug of first choice for atonic seizures and for juvenile myoclonic epilepsy
(JME)

A

Valproic acid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

FDA-approved as adjunctive treatment of myoclonic seizures in patients with JME

A

Levetiracetam

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Alternative agents (3)

A

Lamotrigine, Topiramate, Zonisamide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Levetiracetam is FDA-approved as _________

A

adjunctive treatment of myoclonic seizures in patients with JME

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

viewed as a tool with which to optimize therapy for an individual patient not as a therapeutic endpoint in itself

A

Serum concentrations of the older AEDs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Serum concentration is a target that should be correlated with ______

A

clinical response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

First-line therapy for patients with newly diagnosed partial seizures and for patients with primary generalized convulsive seizures

A

Carbamazepine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Associated with a 1% risk of spina bifida when ingested during
the first trimester of pregnancy

A

Carbamazepine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

congenital disability condition which affects the spine as a type of neural tube defect; can happen anywhere along the spine if the neural tube does not close entirely in the membranes of the spinal cord

A

spina bifida

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Most Common Adverse Effects include neurosensory side effects (diplopia, blurred vision, nystagmus, ataxia, unsteadiness, dizziness and headache); seen in 35%
to 50% of px

A

Carbamazepine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Most Common Adverse Effects include Hematologic side effect (leukopenia - 10% incidence)

A

Carbamazepine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

double vision

A

diplopia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

rapid or uncontrollable eye movement

A

nystagmus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

loss of muscle control or coordination

A

ataxia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Drug Interactions of Carbamazepine are _________

A

very significant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Drugs that inhibit CYP3A4 potentially may increase this AED's serum concentrations
Carbamazepine
25
Second-line agent for patients with partial seizures who have failed initial treatment
Gabapentin
26
Shown to be useful for chronic pain and other non-epileptic conditions
Gabapentin
27
we can also find benefits in this AED for px with less severe seizure disorders in the elderly
Gabapentin
28
Minimal CNS adverse effects and few drug interactions due to broad therapeutic index
Gabapentin
29
CNS adverse effects include ataxia, somnolence, dizziness and fatigue
Gabapentin
30
T/F Drug Interactions are not likely to occur in Gabapentin since this drug does not induce or inhibit liver enzymes
T
31
Gabapentin therapeutic index makes it a (safer/less safer) option
safer
32
Useful as both monotherapy and adjunctive treatment in patients with partial seizures
Lamotrigine
33
Useful alternative for primary generalized seizure types
Lamotrigine
34
Adjunctive therapy for primary GTC seizures
Lamotrigine
35
as monotherapy, it has comparable efficacy with more traditional AEDs such as carbamazepine and phenytoin
Lamotrigine
36
Most frequently reported A/E: diplopia, drowsiness, ataxia, headaches
Lamotrigine
37
A/E are more common when given in combination with other AEDs
Lamotrigine
38
observed more in carbamazepine + lamotrigine
diplopia
39
manifested more in lamotrigine + valproic acid
tremors
40
diplopia is common in the combination of ____________
carbamazepine + lamotrigine
41
tremors is common in the combination of ____________
lamotrigine + valproic acid
42
Drug has Low potential for pharmacokinetic drug interactions and Do not induce or inhibit liver enzymes
Lamotrigine
43
Indicated for patients with partial seizures who have failed initial therapy
Levetiracetam
44
Approved for adjunctive treatment of myoclonic seizures in patients with JME
Levetiracetam
45
Adjunctive treatment of primarily generalized seizures in patients with idiopathic generalized epilepsy
Levetiracetam
46
Adverse Effects of this AED Appears to be modest
Levetiracetam
47
Most common CNS effects (sedation, fatigue, and coordination difficulties)
Levetiracetam
48
drug Does not induce or inhibit liver enzymes and does not appear to interact with other AEDs, warfarin, digoxin, or oral contraceptive drugs
Levetiracetam
49
T/F Oxcarbazepine is indicated for use as monotherapy
T
50
Adjunctive therapy in the treatment of partial seizures in adults and children as young as four years of age
Oxcarbazepine
51
Potential first-line drug for patients with primary generalized convulsive seizures
Oxcarbazepine
52
May also be effective in patients not demonstrating a response to carbamazepine
Oxcarbazepine
53
fewer S/E than phenytoin, carbamazepine, and valproic acid
Oxcarbazepine
54
Most frequently reported S/E: dizziness, nausea, headache, diarrhea, vomiting, URTI, constipation, dyspepsia, ataxia, and nervousness
Oxcarbazepine
55
Decreases the bioavailability and pharmacologic activity of ethinyl estradiol and levonorgestrel
Oxcarbazepine
56
ethinyl estradiol and levonorgestrel drug class
oral contraceptives
57
Drug of choice for neonatal seizures
Phenobarbital
58
Reserved for patients who have failed therapy with other AEDs
Phenobarbital
59
May be useful given IV in refractory status epilepticus
Phenobarbital
60
life-threatening condition when seizures persist despite administration of both 1st line and 2nd line medications
status epilepticus
61
advantage: available in Multiple dosage forms available
Phenobarbital
62
T/F phenytoin is available in oral solid, oral liquid, IM, IV
F - phenobarbital
63
Most inexpensive AED
Phenobarbital
64
primary factors limiting the use of phenobarbital
CNS side effects
65
Adverse Effects: Hyperactivity in children
Phenobarbital
66
May also cause porphyria and rashes as serious as SJS
Phenobarbital
67
Potent enzyme inducer (increases elimination of any drug metabolized by CYP450)
Phenobarbital
68
First-line AED for primary generalized convulsive and partial seizures
Phenytoin
69
CNS depressant effects (lethargy, fatigue, incoordination, blurred vision, higher cortical dysfunction, and drowsiness)
Phenytoin
70
adverse effects on CNS are usually transient, can be minimized by slow dosage titration
Phenytoin
71
T/F if newer AEDs are available, phenytoin would be a lower priority
T
72
T/F Phenytoin is Associated with minimal drug interaction
F - numerous drug interaction
73
drug interactions Involve altered absorption, metabolism, protein binding; May enhance or reduce its effects
Phenytoin
74
Dosing Must be in mg PE
Phenytoin
75
dosing unit of phenytoin
mg phenytoin equivalents or PE
76
75 mg fosphenytoin is equal to ____ mg phenytoin sodium
50
77
Second-line agent for patients with partial seizures who have failed initial treatment
Pregabalin
78
Useful for chronic neuropathic pain and generalized anxiety disorder
Pregabalin
79
Most frequently reported A/E: dizziness, ataxia, blurred vision, and weight gain
Pregabalin
80
Drug Interactions are Unlikely to happen, predominantly excreted unchanged in the urine and undergoes negligible metabolism
Pregabalin
81
First-line AED for partial seizures as an adjunct and/or monotherapy
Topiramate
82
Approved for the treatment of tonic-clonic seizures in primary generalized epilepsy
Topiramate
83
T/F most A/Es occur irregardless of how topiramate is administered; whether in high doses or rapid titration
F
84
Slow dosage titration and increments (increments must be assessed in 1 to 2 weeks)
Topiramate
85
Main: ataxia, impaired concentration, memory difficulties, attentional deficits, fatigue, paresthesia, somnolence, and “thinking abnormally” which rarely has included psychosis
Topiramate
86
Cognitive dysfunctions in concomitant therapy with topiramate, valproic acid, or phenobarbital
Topiramate
87
Cognitive dysfunctions from Topiramate arise in concomitant therapy with _________, __________, or ________
topiramate, valproic acid, phenobarbital
88
First-line therapy for primary generalized seizures including myoclonic, atonic, and absence seizures
Valproic Acid or Divalproex Sodium
89
Used as both monotherapy and adjunctive therapy for partial seizures
Valproic Acid or Divalproex Sodium
90
Useful in patients with mixed seizure disorders
Valproic Acid or Divalproex Sodium
91
Most frequently reported: Gastrointestinal symptoms w/ 20% incidence (nausea, vomiting, anorexia and weight gain)
Valproic Acid or Divalproex Sodium
92
T/F GI complains in valproic acid can be completely alleviated
F
93
how to Minimize GI complaints from Valproic Acid or Divalproex Sodium?
enteric-coated formulation or by giving the drug with food
94
A/E: Alopecia and hair changes (temporary)
Valproic Acid or Divalproex Sodium
95
Most serious side effect of Valproic Acid or Divalproex Sodium
hepatotoxicity
96
Highly protein-bound, can be displaced by other drugs
Valproic Acid or Divalproex Sodium
97
Approved for the adjunctive treatment of partial seizures
Zonisamide
98
Most common: somnolence, dizziness, anorexia, headache, nausea, agitation, word-finding difficulties, irritability; usually dose, dependent
Zonisamide
99
T/F Zonisamide does not induce or inhibit liver enzymes
T
100
Should be avoided in patients allergic to sulfa drugs
Zonisamide